Ora Biomedical, Inc. is thrilled to join Krister Kauppi - Rapamycin Longevity Lab and visionary donors in rapidly advancing our understanding of mTOR as a target for lifespan extension!

Congratulations to Ora Biomedical, Inc. on fully funding subproject one - the first phase in a project that seeks out next-gen therapies more effective than rapamycin. Learn more and contribute: lifespan.io/news/the-mtor-… Krister Kauppi - Rapamycin Longevity Lab Mitchell B Lee, PhD keithcomito.eth Lifespan Research Institute

Congratulations Krister Kauppi - Rapamycin Longevity Lab , Mitchell B Lee, PhD , Matt Kaeberlein and moreover everyone who stands to benefit from this research: all of us. ⚕️

João Paulo Pelúzio I mention a few paths in the video. The Ora Biomedical, Inc. Million Molecule Challenge is the one that I think has the most potential for novel intervention discovery. Large multiomic human data sets will help with personalizing and optimizing what is currently possible but unlikely

Pioneers in aging research are telling us what we're missing. At Ora Biomedical, Inc., we're listening. youtu.be/hySlWn0f9m8?si…

This week on A4LI’s Scientist Spotlight, we sit down with Dr. Kenneth Wilson (Kenny Wilson ), a postdoctoral researcher in Dr. Lisa Ellerby's lab at the Buck Institute. In this episode, we discuss Kenny's first contributions to the aging field, his rise to prominence, as well as

1 week until D.C. Summit 2025 @TheA4li Speakers include: Robert (Bobby) Brooke Eric Morgen Eric Verdino Joe Betts-LaCroix Katerina Stroponiati Kristen Fortney Matt Kaeberlein Mitchell B Lee, PhD Sonia Arrison Louis Hawthorne Alexandra S. Bause Christin Glorioso, MD PhD🏳️‍🌈 Karl Pfleger Petr Sramek liveforever.club/events?selecte…

The PEARL trial tested rapamycin's effect on human healthspan and the results are in! Learn more from lead author Sajad Zalzala, MD of AgelessRx, Ora Biomedical, Inc. co-founder Matt Kaeberlein, and LifespanIO co-founder keithcomito.eth: lifespan.io/news/results-o… By: Josh Conway Lifespan Research Institute

onlinelibrary.wiley.com/doi/10.1111/ac…

The Alliance for Longevity Initiatives applauds today’s relaunch of the Congressional Caucus for Longevity Science, a bipartisan effort that signals growing momentum for policies that prioritize aging and longevity research. Led by Representatives Gus Bilirakis (R-FL),

This is great news leading into the The Alliance for Longevity Initiatives (A4LI) summit next week. Huge thank you to the bipartisan group of representatives leading the way on better health for all Americans through support for longevity science. Gus Bilirakis (R-FL), Paul Tonko (D-NY), Dan Crenshaw

For those who may not be familiar, the Alliance for Longevity Initiatives (A4LI) is dedicated to advancing congressional support for increased funding and regulatory reforms related to aging biology and longevity science (geroscience). You can learn more about their work at

Just launched: Defense and Space Applications of Longevity Science Panel. Very important topics we don’t discuss often in the longevity space. Glad we are the ones to introduce it! MC: Jeremy Elser Chris Steele, PhD Bob S. Walker Mitchell Lee, PhD (Ora Biomedical, Inc.)

Thank you Gus Bilirakis, Paul Tonko, and Dr. Mehmet Oz for your bold bipartisan leadership at this morning’s U.S. Longevity Initiatives Congressional Briefing. Your commitment to advancing longevity science and prevention has the power to shift public health from a reactive focus

Our Congressional Briefing on Longevity Science is underway! We're deeply grateful to our Longevity Science Caucus co-chairs, Gus Bilirakis and Paul Tonko, for their inspiring opening remarks followed by insights from Dr. Mehmet Oz. The conversation continues with a dynamic panel

Ora Biomedical, Inc. Matt Kaeberlein Benjamin W Blue Alessandro Bitto Brian Kennedy Mitchell B Lee, PhD This is such an inspiring initiative! The blend of citizen science, AI, and longevity research is exactly the kind of future-forward approach we need. Count me in—let’s help reshape the future of health, one molecule at a time. @sharafi_eth

Buck CEO Eric Verdin joins Matt Kaeberlein @dogagingproject and Mike Roizin from Cleveland Clinic for a day of congressional lobbying for funding for research on aging. @TheA4LI a4li.org/dc-summit-2025/

Yesterday, we at A4LI kicked off our second annual fly-in congressional briefing — and we are proud to have been featured in the latest addition of @Politico Influence! 🧬 Thank you to Gus Bilirakis, Paul Tonko & Dr. Mehmet Oz for helping us kick off a day of 50+ Hill

𝗢𝘂𝗿 𝗗.𝗖. 𝗦𝘂𝗺𝗺𝗶𝘁 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹 𝗕𝗿𝗶𝗲𝗳𝗶𝗻𝗴 𝗶𝘀 𝗻𝗼𝘄 𝗹𝗶𝘃𝗲 𝗼𝗻 𝗬𝗼𝘂𝗧𝘂𝗯𝗲! We were honored to feature opening remarks from Longevity Science Caucus Co-Chairs, Representative Gus Bilirakis (FL-12) and Representative Paul Tonko (NY-20),

We’re thrilled to announce that we’ve reached 28% funding for our second subproject, where we’ll screen the remaining 300 mTOR inhibitors! The goal is to uncover the next breakthrough beyond the mTOR inhibitor Rapamycin, which is currently the most promising longevity compound